Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
NCT01492569 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2013-06-12
Summary
This randomized pilot clinical trial studies giving acupuncture in reducing nausea and vomiting in patients undergoing chemotherapy. Pressing and stimulating nerves at an acupuncture point on the inside of the wrist may help control nausea and vomiting during chemotherapy.
Conditions
- Childhood Acute Lymphoblastic Leukemia
- Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
- Ewing Sarcoma
- Vomiting in Infants and/or Children
- Osteosarcoma
Interventions
- PROCEDURE
-
electroacupuncture therapy
Undergo TAPS at sham point
- OTHER
-
questionnaire administration
Ancillary studies
- PROCEDURE
-
electroacupuncture therapy
Undergo TAPS
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Brenda Golianu · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 8 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-07-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)
NCT07209501 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Nausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung Cancer
NCT00416689 ·Status: COMPLETED
-
Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
NCT00716157 ·Status: COMPLETED
-
Efficacy of Aprepitant (Emend®) in Children
NCT01661335 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy
NCT01402024 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Short-term Therapeutic Fasting on Nausea and Vomiting Due to Chemotherapy
NCT04141514 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy
NCT07130617 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting
NCT07246070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prevalence of Delayed Chemotherapy Associated Nausea
NCT04342780 ·Status: COMPLETED
-
Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy
NCT04785495 ·Status: UNKNOWN
-
Chemoradiation-Induced Nausea and Emesis: Quality of Life
NCT00394602 ·Status: TERMINATED
-
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)
NCT01362530 ·Status: COMPLETED ·Phase: PHASE3
-
Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)
NCT00952341 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
NCT04937309 ·Status: UNKNOWN ·Phase: NA
-
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)
NCT00211601 ·Status: COMPLETED ·Phase: NA
-
Prevention of Unmitigated Chemotherapy-induced Emesis
NCT03996863 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
NCT01757210 ·Status: COMPLETED
-
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)
NCT00818259 ·Status: TERMINATED ·Phase: PHASE1
-
Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy
NCT01661413 ·Status: COMPLETED
-
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
NCT00880191 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Medical Taping Concept in Cancer Patients
NCT02823314 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting
NCT01937156 ·Status: COMPLETED ·Phase: PHASE3
-
Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents
NCT04472143 ·Status: UNKNOWN ·Phase: PHASE2
-
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
NCT07217600 ·Status: RECRUITING ·Phase: PHASE4
-
To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)
NCT00273468 ·Status: COMPLETED ·Phase: PHASE3